Search
for
Sort by
Research 61–90 of 1000+
- JAK Inhibitor Safety in Atopic Dermatitis and Alopecia Areata: A 4.5-Year Real-World Retrospective Cohort Study
- Low-Dose Oral Minoxidil Beyond Androgenetic Alopecia: A Comparative Narrative Review of Emerging Evidence
- Testosterone Therapy in Women: A Literature Review of Clinical Indications, Dosing, Routes of Administration, and Safety
- Baricitinib: Exploring the Safety Profile for the Treatment of Alopecia Areata
- Nitroglycerin in Dermatology
- Androgen Therapy in Women: An Endocrine Society Clinical Practice Guideline
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Safety of testosterone treatment in postmenopausal women
- TELECONSULTA EM INSUFICIÊNCIA CARDÍACA: REVISÃO DE ESCOPO
- Alopecia androgenética: O uso do minoxidil e seus efeitos adversos
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- News in brief ???
- Aldesleukin
- The mineralocorticoid receptor as a novel player in skin biology: beyond the renal horizon?
- The Role of Androgens in Health and Disease in Females: A Narratıve Review
- Minoxidil.
- BPH: epidemiology and comorbidities.
- Testosterone therapy for sexual dysfunction in postmenopausal women
- Bubble-Based Drug Delivery Systems: Next-Generation Diagnosis to Therapy
- Emerging role of baricitinib in dermatology practice: All we need to know!
- Medical consequences of long-term anabolic-androgenic Steroids (AASs) abuses in athletes
- [Female contraception: hormonal methods].
- Targets to treat androgen excess in polycystic ovary syndrome
- Drugs that affect autonomic functions or the extrapyramidal system
- Anti-anginal and beta-adrenoceptor blocking drugs
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective
- Progestogens in menopausal hormone therapy
- New drugs: Agalsidase beta
- New drugs: Iobenguane sulfate
- Complications associated with oncological therapy - how to minimize?